001     126273
005     20240228140819.0
024 7 _ |a 10.1007/s00401-014-1363-2
|2 doi
024 7 _ |a pmid:25394388
|2 pmid
024 7 _ |a pmc:PMC4309020
|2 pmc
024 7 _ |a 0001-6322
|2 ISSN
024 7 _ |a 1432-0533
|2 ISSN
024 7 _ |a altmetric:2885675
|2 altmetric
037 _ _ |a DKFZ-2017-02388
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Clemen, Christoph S
|b 0
245 _ _ |a The toxic effect of R350P mutant desmin in striated muscle of man and mouse.
260 _ _ |a Berlin
|c 2015
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1508404843_7040
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Mutations of the human desmin gene on chromosome 2q35 cause autosomal dominant, autosomal recessive and sporadic forms of protein aggregation myopathies and cardiomyopathies. We generated R349P desmin knock-in mice, which harbor the ortholog of the most frequently occurring human desmin missense mutation R350P. These mice develop age-dependent desmin-positive protein aggregation pathology, skeletal muscle weakness, dilated cardiomyopathy, as well as cardiac arrhythmias and conduction defects. For the first time, we report the expression level and subcellular distribution of mutant versus wild-type desmin in our mouse model as well as in skeletal muscle specimens derived from human R350P desminopathies. Furthermore, we demonstrate that the missense-mutant desmin inflicts changes of the subcellular localization and turnover of desmin itself and of direct desmin-binding partners. Our findings unveil a novel principle of pathogenesis, in which not the presence of protein aggregates, but disruption of the extrasarcomeric intermediate filament network leads to increased mechanical vulnerability of muscle fibers. These structural defects elicited at the myofiber level finally impact the entire organ and subsequently cause myopathy and cardiomyopathy.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Desmin
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a Recombinant Proteins
|2 NLM Chemicals
700 1 _ |a Stöckigt, Florian
|b 1
700 1 _ |a Strucksberg, Karl-Heinz
|b 2
700 1 _ |a Chevessier, Frederic
|b 3
700 1 _ |a Winter, Lilli
|b 4
700 1 _ |a Schütz, Johanna
|b 5
700 1 _ |a Bauer, Ralf
|b 6
700 1 _ |a Thorweihe, José-Manuel
|b 7
700 1 _ |a Wenzel, Daniela
|b 8
700 1 _ |a Schlötzer-Schrehardt, Ursula
|b 9
700 1 _ |a Rasche, Volker
|b 10
700 1 _ |a Krsmanovic, Pavle
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Katus, Hugo A
|b 12
700 1 _ |a Rottbauer, Wolfgang
|b 13
700 1 _ |a Just, Steffen
|b 14
700 1 _ |a Müller, Oliver J
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Friedrich, Oliver
|b 16
700 1 _ |a Meyer, Rainer
|b 17
700 1 _ |a Herrmann, Harald
|0 P:(DE-He78)7892a89fee19b8e3912c7423d660765d
|b 18
|u dkfz
700 1 _ |a Schrickel, Jan Wilko
|b 19
700 1 _ |a Schröder, Rolf
|b 20
773 _ _ |a 10.1007/s00401-014-1363-2
|g Vol. 129, no. 2, p. 297 - 315
|0 PERI:(DE-600)1458410-4
|n 2
|p 297 - 315
|t Acta neuropathologica
|v 129
|y 2015
|x 1432-0533
909 C O |o oai:inrepo02.dkfz.de:126273
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)7892a89fee19b8e3912c7423d660765d
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ACTA NEUROPATHOL : 2015
920 1 _ |0 I:(DE-He78)B065-20160331
|k B065
|l Funktionelle Zellarchitektur
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B065-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21